: Nestle works on new range of weight-loss drug companion products as sales miss estimates

Nestle posted worse-than-expected results for the first nine months of 2023 as its revenues were hit by divestments and unfavorable exchange rates

Previous post Movers & Shakers: Netflix shares surge as streaming site hikes prices while Tesla stock slumps after Musk’s comments
Next post Next Avenue: Should you start a business in your 50s or 60s? Here’s how to find financing and build a new career.